Robert Fruscio
Robert Fruscio
San Gerardo Hospital, University of Milan-Bicocca
Verified email at - Homepage
Cited by
Cited by
Simple ultrasound rules to distinguish between benign and malignant adnexal masses before surgery: prospective validation by IOTA group
D Timmerman, L Ameye, D Fischerova, E Epstein, GB Melis, S Guerriero, ...
bmj 341, 2010
microRNA-181a has a critical role in ovarian cancer progression through the regulation of the epithelial–mesenchymal transition
A Parikh, C Lee, P Joseph, S Marchini, A Baccarini, V Kolev, C Romualdi, ...
Nature communications 5 (1), 1-16, 2014
Gynecologic cancers in pregnancy: guidelines of a second international consensus meeting
F Amant, MJ Halaska, M Fumagalli, KD Steffensen, C Lok, ...
International Journal of Gynecologic Cancer 24 (3), 2014
Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary …
B Van Calster, K Van Hoorde, L Valentin, AC Testa, D Fischerova, ...
Bmj 349, 2014
PRL-3 phosphatase is implicated in ovarian cancer growth
F Polato, A Codegoni, R Fruscio, P Perego, C Mangioni, S Saha, ...
Clinical cancer research 11 (19), 6835-6839, 2005
Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections
S Marchini, D Cavalieri, R Fruscio, E Calura, D Garavaglia, IF Nerini, ...
The lancet oncology 12 (3), 273-285, 2011
Predicting the risk of malignancy in adnexal masses based on the Simple Rules from the International Ovarian Tumor Analysis group
D Timmerman, B Van Calster, A Testa, L Savelli, D Fischerova, ...
American journal of obstetrics and gynecology 214 (4), 424-437, 2016
Ovarian cancer prediction in adnexal masses using ultrasound‐based logistic regression models: a temporal and external validation study by the IOTA group
D Timmerman, B Van Calster, AC Testa, S Guerriero, D Fischerova, ...
Ultrasound in Obstetrics and Gynecology 36 (2), 226-234, 2010
Resistance to platinum-based chemotherapy is associated with epithelial to mesenchymal transition in epithelial ovarian cancer
S Marchini, R Fruscio, L Clivio, L Beltrame, L Porcu, IF Nerini, D Cavalieri, ...
European journal of cancer 49 (2), 520-530, 2013
Conservative management of early-stage epithelial ovarian cancer: results of a large retrospective series
R Fruscio, S Corso, L Ceppi, D Garavaglia, A Garbi, I Floriani, D Franchi, ...
Annals of oncology 24 (1), 138-144, 2013
Oncological management and obstetric and neonatal outcomes for women diagnosed with cancer during pregnancy: a 20-year international cohort study of 1170 patients
J de Haan, M Verheecke, K Van Calsteren, B Van Calster, RG Shmakov, ...
The Lancet Oncology 19 (3), 337-346, 2018
A phase II, randomized trial of neo-adjuvant chemotherapy comparing a three-drug combination of paclitaxel, ifosfamide, and cisplatin (TIP) versus paclitaxel and cisplatin (TP …
AA Lissoni, N Colombo, A Pellegrino, G Parma, P Zola, D Katsaros, ...
Annals of oncology 20 (4), 660-665, 2009
Total laparoscopic radical hysterectomy and pelvic lymphadenectomy in patients with Ib1 stage cervical cancer: analysis of surgical and oncological outcome
A Pellegrino, E Vizza, R Fruscio, A Villa, G Corrado, M Villa, T Dell'Anna, ...
European Journal of Surgical Oncology (EJSO) 35 (1), 98-103, 2009
Patient-derived ovarian tumor xenografts recapitulate human clinicopathology and genetic alterations
F Ricci, F Bizzaro, M Cesca, F Guffanti, M Ganzinelli, A Decio, C Ghilardi, ...
Cancer research 74 (23), 6980-6990, 2014
Strategies to diagnose ovarian cancer: new evidence from phase 3 of the multicentre international IOTA study
A Testa, J Kaijser, L Wynants, D Fischerova, C Van Holsbeke, D Franchi, ...
British journal of cancer 111 (4), 680-688, 2014
Adnexal masses difficult to classify as benign or malignant using subjective assessment of gray‐scale and Doppler ultrasound findings: logistic regression models do not help
L Valentin, L Ameye, L Savelli, R Fruscio, FPG Leone, A Czekierdowski, ...
Ultrasound in obstetrics & gynecology 38 (4), 456-465, 2011
External validation of diagnostic models to estimate the risk of malignancy in adnexal masses
C Van Holsbeke, B Van Calster, T Bourne, S Ajossa, AC Testa, ...
Clinical Cancer Research 18 (3), 815-825, 2012
Delivery delay with neoadjuvant chemotherapy for cervical cancer patients during pregnancy: a series of nine cases and literature review
R Fruscio, A Villa, S Chiari, P Vergani, L Ceppi, F Dell'Orto, T Dell'Anna, ...
Gynecologic oncology 126 (2), 192-197, 2012
Risk of malignancy in unilocular cysts: a study of 1148 adnexal masses classified as unilocular cysts at transvaginal ultrasound and review of the literature
L Valentin, L Ameye, D Franchi, S Guerriero, D Jurkovic, L Savelli, ...
Ultrasound in obstetrics & gynecology 41 (1), 80-89, 2013
18F-FDG PET/CT can predict nodal metastases but not recurrence in early stage uterine cervical cancer
C Crivellaro, M Signorelli, L Guerra, E De Ponti, A Buda, C Dolci, ...
Gynecologic oncology 127 (1), 131-135, 2012
The system can't perform the operation now. Try again later.
Articles 1–20